Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

14 Nov 2016

Abstract excerpt

Parkinson's disease (PD) and multiple system atrophy (MSA) are both part of the spectrum of neurodegenerative movement disorders and α-synucleinopathies with overlap of symptoms especially at early stages of the disease but with distinct disease progression and responses to dopaminergic treatment. Therefore, having biomarkers that specifically classify patients, which could discriminate PD from MSA, would be very...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27844283
DOI: 10.1007/s12035-016-0253-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System AtrophyPMID 27844283Read ↗

Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's DiseaseSemantic proximity Read ↗

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s diseaseSemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysisSemantic proximity Read ↗

Serum microRNA expression profiling in patients with multiple system atrophySemantic proximity Read ↗

ROLE OF MICRORNAS IN THE PATHOGENESIS OF PARKINSON'S DISEASESemantic proximity Read ↗

Meta-analyses identify differentially expressed microRNAs in Parkinson’s diseaseSemantic proximity Read ↗

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s diseaseSemantic proximity Read ↗

Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s DiseaseSemantic proximity Read ↗

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s DiseaseSemantic proximity Read ↗

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s DiseaseSemantic proximity Read ↗

microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.